Abstract | BACKGROUND: METHODS AND RESULTS: CONCLUSIONS: In contrast to several other chemokines, our findings suggest that SDF-1alpha, at least in high concentrations, may mediate antiinflammatory and matrix-stabilizing effects in unstable angina. These effects may promote plaque stabilization, and therapeutic intervention that enhances SDF-1alpha activity could potentially be beneficial in acute coronary syndromes.
|
Authors | Jan K Damås, Torgun Waehre, Arne Yndestad, Thor Ueland, Fredrik Müller, Hans Geir Eiken, Are M Holm, Bente Halvorsen, Stig S Frøland, Lars Gullestad, Pål Aukrust |
Journal | Circulation
(Circulation)
Vol. 106
Issue 1
Pg. 36-42
(Jul 02 2002)
ISSN: 1524-4539 [Electronic] United States |
PMID | 12093767
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Anti-Inflammatory Agents
- CXCL12 protein, human
- Chemokine CCL2
- Chemokine CXCL12
- Chemokines, CXC
- Cytokines
- Interleukin-8
- RNA, Messenger
- Receptors, CXCR4
- Tissue Inhibitor of Metalloproteinase-1
- Thromboplastin
- Cyclic AMP-Dependent Protein Kinases
- Matrix Metalloproteinase 9
|
Topics |
- Angina, Unstable
(genetics, immunology, metabolism)
- Anti-Inflammatory Agents
(metabolism, pharmacology)
- Cells, Cultured
- Chemokine CCL2
(biosynthesis, genetics)
- Chemokine CXCL12
- Chemokines, CXC
(genetics, pharmacology, physiology)
- Cyclic AMP-Dependent Protein Kinases
(physiology)
- Cytokines
(biosynthesis, genetics)
- Dose-Response Relationship, Drug
- Extracellular Matrix
(metabolism)
- Female
- Humans
- Interleukin-8
(biosynthesis, genetics)
- Leukocytes, Mononuclear
(drug effects, immunology)
- Male
- Matrix Metalloproteinase 9
(biosynthesis, genetics)
- Middle Aged
- RNA, Messenger
(biosynthesis)
- Receptors, CXCR4
(biosynthesis, genetics)
- Thromboplastin
(metabolism)
- Tissue Inhibitor of Metalloproteinase-1
(biosynthesis, genetics)
|
|
Join CureHunter, for free Research Interface BASIC access!
Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease.
Find out why thousands of doctors, pharma researchers and patient activists
around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!
|